Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Design of therapeutic proteins with enhanced stability

Design of therapeutic proteins with enhanced stability

Thumbnail Image
Download
Name

Chennamsetty-2009-Design of therapeuti.pdf

Size

3.26 MB

Format

Adobe PDF

Checksum (MD5)

3aec4fdaf66793a7e127669323ca1fcb

Author(s)
Kayser, Veysel
•
Voynov, Vladimir
•
Chennamsetty, Naresh
•
Trout, Bernhardt L.
•
Helk, Bernhard
Date Issued
May 2009
Journal
Proceedings of the National Academy of Sciences of the United States of America
Publisher
United States National Academy of Sciences
Citation
Chennamsetty, Naresh et al. “Design of therapeutic proteins with enhanced stability.” Proceedings of the National Academy of Sciences 106.29 (2009): 11937-11942. © 2010 National Academy of Sciences
Version
Final published version
Abstract
Therapeutic proteins such as antibodies constitute the most rapidly growing class of pharmaceuticals for use in diverse clinical settings including cancer, chronic inflammatory diseases, kidney transplantation, cardiovascular medicine, and infectious diseases. Unfortunately, they tend to aggregate when stored under the concentrated conditions required in their usage. Aggregation leads to a decrease in antibody activity and could elicit an immunological response. Using full antibody atomistic molecular dynamics simulations, we identify the antibody regions prone to aggregation by using a technology that we developed called spatial aggregation propensity (SAP). SAP identifies the location and size of these aggregation prone regions, and allows us to perform target mutations of those regions to engineer antibodies for stability. We apply this method to therapeutic antibodies and demonstrate the significantly enhanced stability of our mutants compared with the wild type. The technology described here could be used to incorporate developability in a rational way during the screening of antibodies in the discovery phase for several diseases.
MIT Department
Massachusetts Institute of Technology. Department of Chemical Engineering
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
http://hdl.handle.net/1721.1/52552
DOI of Published Version
http://dx.doi.org/10.1073/pnas.0904191106
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.